Brief: Cullinan Oncology Q3 Net Income USD -40.56 Million
07/11/2024 12:00
Nov 07 (Reuters) - Cullinan Oncology Q3 operating income USD -48.855 million. * Q3 operating expenses USD 48.855 million * Q3 cash & investments USD 639 million
CGEM — Cullinan Therapeutics News Story
0.000.00%
Last trade - 00:00- $960.17m
- $625.63m